Published in Cancer Weekly, May 6th, 1996
In the April 16, 1996, issue of the Journal of Oral Pathology and Medicine, an article entitled "Sensitivity and Specificity of OraScan Toluidine Blue Mouthrinse in the Detection of Oral Cancer and Precancer," reported that the oral squamous cell carcinomas were "detected with a 100 percent sensitivity using the OraScan rinse with 1 percent toluidine blue as the active ingredient."
The article was authored by K.A.A.S. Warnakulasuriya and Newell W. Johnson, both of the Royal College of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.